EP0749314A4 - Procede de traitement et d'inhibition des ulceres gastriques et duodenaux - Google Patents

Procede de traitement et d'inhibition des ulceres gastriques et duodenaux

Info

Publication number
EP0749314A4
EP0749314A4 EP95911945A EP95911945A EP0749314A4 EP 0749314 A4 EP0749314 A4 EP 0749314A4 EP 95911945 A EP95911945 A EP 95911945A EP 95911945 A EP95911945 A EP 95911945A EP 0749314 A4 EP0749314 A4 EP 0749314A4
Authority
EP
European Patent Office
Prior art keywords
treating
duodenal ulcers
inhibiting gastric
gastric
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95911945A
Other languages
German (de)
English (en)
Other versions
EP0749314A1 (fr
Inventor
David A Zopf
Paul M Simon
Stephen Roth
Edward J Mcguire
Dennis H Langer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neose Technologies Inc
Original Assignee
Neose Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neose Technologies Inc filed Critical Neose Technologies Inc
Publication of EP0749314A1 publication Critical patent/EP0749314A1/fr
Publication of EP0749314A4 publication Critical patent/EP0749314A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
EP95911945A 1994-03-02 1995-03-02 Procede de traitement et d'inhibition des ulceres gastriques et duodenaux Withdrawn EP0749314A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20451594A 1994-03-02 1994-03-02
US204515 1994-03-02
PCT/US1995/002388 WO1995023605A1 (fr) 1994-03-02 1995-03-02 Procede de traitement et d'inhibition des ulceres gastriques et duodenaux

Publications (2)

Publication Number Publication Date
EP0749314A1 EP0749314A1 (fr) 1996-12-27
EP0749314A4 true EP0749314A4 (fr) 2002-09-18

Family

ID=22758224

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95911945A Withdrawn EP0749314A4 (fr) 1994-03-02 1995-03-02 Procede de traitement et d'inhibition des ulceres gastriques et duodenaux

Country Status (5)

Country Link
EP (1) EP0749314A4 (fr)
JP (1) JP3179108B2 (fr)
AU (1) AU709149B2 (fr)
CA (1) CA2183329A1 (fr)
WO (1) WO1995023605A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
AU710576B2 (en) * 1996-05-03 1999-09-23 Neose Technologies, Inc. Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
AU2745700A (en) 1999-02-01 2000-08-18 Dermal Research Laboratories, Inc. A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
SE9901007D0 (sv) * 1999-03-19 1999-03-19 Thomas Boren Use of fucosylated sialylated N-acetyl lactosamin carbohydrate structures for inhibition of bacterial adherence
US7879824B2 (en) 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
NL2007931C2 (en) * 2011-12-07 2013-06-10 Friesland Brands Bv Methods for providing sialylated oligosaccharides and products obtainable thereby.
US12138308B2 (en) 2018-09-20 2024-11-12 Enbiar Inc. Polymer composite for helicobacter pylori recognition and composition for photodynamic therapy comprising same
JP7168770B2 (ja) * 2018-09-20 2022-11-09 エンビアル インコーポレイテッド ヘリコバクター・ピロリ認知用高分子複合体及びそれを含む光線力学治療用組成物

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662697A1 (fr) * 1990-06-01 1991-12-06 Snow Brand Milk Products Co Ltd Nouveau ganglioside provenant du lait et son procede d'obtention.
WO1993018775A1 (fr) * 1992-03-19 1993-09-30 The University Of British Columbia Procede et composition permettant de supprimer les effets secondaires de medicaments anti-inflammatoires
WO1993023055A1 (fr) * 1992-05-15 1993-11-25 The University Of British Columbia Glucosamine d'acetyle-n en tant qu'agent gastroprotecteur
WO1994003184A1 (fr) * 1992-07-31 1994-02-17 Neose Pharmaceuticals, Inc. Compositions destinees a traiter et inhiber les ulceres gastriques et duodenaux

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE464687B (sv) * 1987-11-10 1991-06-03 Biocarb Ab Foerfarande foer framstaellning av en gelprodukt
US5089479A (en) * 1988-11-28 1992-02-18 Krivan Howard C Adhesion of mycoplasma pneumoniae and mycoplasma hominus to sulfatide
US5260280A (en) * 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
US5211937A (en) * 1990-07-30 1993-05-18 Glycomed Incorporated Method of determining a site of inflammation utilizing elam-1 ligands
US5164374A (en) * 1990-12-17 1992-11-17 Monsanto Company Use of oligosaccharides for treatment of arthritis
US5254676A (en) * 1991-11-22 1993-10-19 E. I. Du Pont De Nemours And Company Oligosaccharide inhibitors for influenza virus

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662697A1 (fr) * 1990-06-01 1991-12-06 Snow Brand Milk Products Co Ltd Nouveau ganglioside provenant du lait et son procede d'obtention.
WO1993018775A1 (fr) * 1992-03-19 1993-09-30 The University Of British Columbia Procede et composition permettant de supprimer les effets secondaires de medicaments anti-inflammatoires
WO1993023055A1 (fr) * 1992-05-15 1993-11-25 The University Of British Columbia Glucosamine d'acetyle-n en tant qu'agent gastroprotecteur
WO1994003184A1 (fr) * 1992-07-31 1994-02-17 Neose Pharmaceuticals, Inc. Compositions destinees a traiter et inhiber les ulceres gastriques et duodenaux

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FALK P ET AL: "AN IN VITRO ADHERENCE ASSAY REVEALS THAT HELICOBACTER PYLORI EXHIBITS CELL LINEAGE-SPECIFIC TROPISM IN THE HUMAN GASTRIC EPITHELIUM", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 90, no. 5, 1 March 1993 (1993-03-01), pages 2035 - 2039, XP000560389, ISSN: 0027-8424 *
See also references of WO9523605A1 *

Also Published As

Publication number Publication date
AU1932395A (en) 1995-09-18
JPH09509931A (ja) 1997-10-07
AU709149B2 (en) 1999-08-19
CA2183329A1 (fr) 1995-09-08
JP3179108B2 (ja) 2001-06-25
EP0749314A1 (fr) 1996-12-27
WO1995023605A1 (fr) 1995-09-08

Similar Documents

Publication Publication Date Title
SG55323A1 (en) Substrate treating system and substrate treating method
SG32522A1 (en) Surface treatment method and system
SG73986A1 (en) Method for treating bioorganic and wastewater sludges
SG65007A1 (en) Substrate treatment system substrate transfer system and substrate transfer method
IL112958A0 (en) Method for treating 5ht2b receptor related conditions
ZA965088B (en) Methods of preventing or treating allergles
ZA959168B (en) Method for treating anxiety
AU8095491A (en) Method and device for treating epilepsy
ZA952022B (en) Method for treating 5HT2B receptor related conditions
AU4993893A (en) Compositions for treating and inhibiting gastric and duodenal ulcers
AU1912992A (en) Method for treating hypothermia
GB2264341B (en) Pipe treating method and apparatus
AU1932395A (en) Method for treating and inhibiting gastric and duodenal ulcers
GB2289982B (en) Apparatus and method for manufacturing wafer
HU9503330D0 (en) Process for treating sewage
IL116309A0 (en) Method and installation for treating a medium
EP0562848A3 (en) Surface treating method
EP0783304A4 (fr) Methode de traitement de l'anxiete
EP0769904A4 (fr) Methode de traitement de l'anxiete
AU2732697A (en) Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
AU7691291A (en) Method of treating gastric ulcers and obesity
AU2148792A (en) Method and device for treating wastewater
IL105522A0 (en) Substrate treatment method and apparatus
GB9517701D0 (en) Method for treating hyperlipidemia
GB2299711B (en) Apparatus for making or treating a semiconductor

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960828

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NEOSE TECHNOLOGIES, INC.

A4 Supplementary search report drawn up and despatched

Effective date: 20020805

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 31/715 A, 7A 61K 31/70 B, 7A 61K 45/06 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20021022